Updating your news feed...

NEWS EXPRESS is Nigeria’s leading online newspaper. Published by Africa’s international award-winning journalist, Mr. Isaac Umunna, NEWS EXPRESS is Nigeria’s first truly professional online daily newspaper. It is published from Lagos, Nigeria’s economic and media hub, and has a provision for occasional special print editions. Thanks to our vast network of sources and dedicated team of professional journalists and contributors spread across Nigeria and overseas, NEWS EXPRESS has become synonymous with newsbreaks and exclusive stories from around the world.
























Loading banners
Loading banners...


Plateau State governor, Simon Lalong
By MARIE-THERESE NANLONG
The Plateau State COVID-19 medical research team which was established by the State Governor, Simon Lalong to find a cure for the COVID-19 disease has presented an interim report to the Governor after briefing him on the progress made on the research work.
Lead Researcher, Professor Noel Wannang from the University of Jos explained his team has concluded the first phase of the work which is the pre-clinical stage with “tremendous success,” and the team is at the next stage which is the clinical stage where the samples will be tested on human beings for further processing.
Briefing the Governor at the Government House in Jos, he stated that already the research papers for the remedies have been published in national and international medical journals and the team has patented the products under the name COPLA I, II & III and has equally submitted them to regulatory agencies for further scrutiny and evaluation stressing,
“In the course of its work, the team followed all global standards and protocols for the research and if followed to conclusion, the outcome will not only generate value to the State, but also create economic opportunities.”
Governor Lalong while responding said he was proud of the team for the level of achievements so far, promising to also reach out to relevant government and private sector organisations for further funding of the research. (Text, excluding headline, courtesy Saturday Vanguard)